Quality Choicehydrocortisone

According to the FDA label: Uses for the temporarily relief nasal congestion due to: common cold hay fever upper respiratory allergies

111,859 adverse event reports submitted to the FDA (2001–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Quality Choice in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Quality Choice adverse event reports by reporter sex
SexReports
Female61,984
Male38,027
Unknown195

By Age Group

View age group data as a table
Quality Choice adverse event reports by reporter age group
Age groupReports
0-178,725
18-347,708
35-4913,767
50-6419,334
65-7415,598
75+13,012

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Quality Choice. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Quality Choice adverse event reports by reported outcome
OutcomeReports
Other Serious62,965
Hospitalization49,563
Non-Serious18,735
Death16,032
Life-Threatening13,199
Disability8,785

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Quality Choice. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Quality Choice adverse event reports by year
YearReports
20011
20022
20035
2004933
20051,066
2006932
20071,044
20081,096
20091,309
20102,104
20114,274
20124,936
20132,555
20142,918
20154,257
20165,021
20175,556
20187,313
20197,339
20208,504
20218,923
202210,002
20239,406
202410,348
202510,007
2026 (partial)2,008

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Quality Choice

In FDA adverse event reports that mention Quality Choice, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026